|
|
Investigating Mechanisms of Neurodegeneration in Transgenic Mouse Models of Tauopathies |
| 1 F30 AG067673-01A1 |
|
NIA |
2021 |
|
|
Defining the cell-autonomous role of caveolin-1 in adult hippocampal neurogenesis in Alzheimer's Disease |
| 1 F30 AG071144-01A1 |
|
NIA |
2021 |
|
|
Investigating the Neuronal Signals Initiating Synapse Loss in Aging and Alzheimer's Disease |
| 1 F30 AG074629-01 |
|
NIA |
2021 |
|
|
Effects of apolipoprotein E isoform and amifostine on memory-related DNA double strand breaks and immediate-early gene expression |
| 1 F31 AG067629-01A1 |
|
NIA |
2021 |
|
|
Targeting multiple Wnt inhibitors for synergistic anabolic action in the skeleton |
| 1 F31 AG069489-01A1 |
|
NIA |
2021 |
|
|
Alternative Splicing of ApoER2 in Alzheimers Disease |
| 1 F31 AG069498-01A1 |
|
NIA |
2021 |
|
|
Dissecting the role of hippocampal exosomes in Alzheimer's disease pathogenesis |
| 1 F31 AG071119-01A1 |
|
NIA |
2021 |
|
|
Dysfunction of microglial proteostasis drives neuroinflammation and cognitive decline following pneumonia |
| 1 F31 AG071225-01 |
|
NIA |
2021 |
|
|
Tet-mediated Epigenetic Regulation in Alzheimer's Disease |
| 1 F31 AG072907-01 |
|
NIA |
2021 |
|
|
Sleep disruption in the progression and treatment of Alzheimers disease |
| 1 F31 AG074649-01 |
|
NIA |
2021 |